Glycemic control and pulmonary function sustained throughout long-term use of inhalable insulin

News
Article

Two studies evaluating the efficacy and long-term safety of the inhalable, rapid-acting dry powder insulin formulation (Exubera, Pfizer/Aventis) demonstrate that the drug was able to sustain glycemic control and pulmonary function in patients with type 2 diabetes

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Recent Videos
Sean M. Oser, MD, MPH, an expert on diabetes
Sean M. Oser, MD, MPH, an expert on diabetes
Sean M. Oser, MD, MPH, an expert on diabetes
© 2025 MJH Life Sciences

All rights reserved.